Privacy AI
Regulatory

Health data compliance, handled.

Tell us what you need. We'll tell you what it takes and how long, before you commit.

Contact us

Summary

Contact us
On November 1st, the United Kingdom (UK) published the Bletchley Declaration on the opening day of the Artificial Intelligence (AI) Safety Summit hosted at Bletchley Park, central England.This declaration, made by the UK and joined by 28 countries and international organizations, aims to promote cooperation among them regarding AI.

Why Bletchley ? It was at Bletchley Park that the Enigma code was successfully deciphered during WW2 …

International efforts are being made to examine and address the potential impact of AI systems, especially on principles such as the protection of human rights, data protection, and ethics.👉🏻 The primary focus of this declaration is on Frontier AI. These AI are defined as highly capable general-purpose AI models and specific narrow AI that could exhibit capabilities causing harm

The core concerns of the organizations revolve around the risks posed by Frontier AI, particularly in the domains of cybersecurity and biotechnology. Through international cooperation, they aim to deepen their understanding of these risks and identify actions to address them.

A regulatory approach will be considered by the participating organizations. This includes making, where appropriate, classifications and categorizations of risk based on national circumstances and applicable legal frameworks. International codes of conduct may result from this cooperation.

All AI actors are affected by this Declaration. Actors who develop Frontier AI have a significant responsibility to ensure the safety of these systems. The organizations encourage these actors to provide context-appropriate transparency and accountability in their plans to measure, monitor, and mitigate potentially harmful capabilities and associated effects, particularly to prevent misuse and issues of control, as well as the amplification of other risks.

Click here to read more

Contact us

FAQs

Our frequently questions

No items found.

Seamus Larroque

CDPO / CPIM / ISO 27005 Certified

Find out how iliomad can help your company.

[Map placeholder]
Only visible in production
38.709099
-39.182035
1.6
6d17042a3425c5b3
Your message has been received!
We'll get back to you as soon as possible.
Something went wrong, please try again.
Home

Discover our latest articles

View All Blog Posts
Illustration of the CNIL MR-001 framework applied to a clinical trial data compliance workflow in France, showing patient data flow and security controls
September 7, 2026
GDPR
Regulation
Guideline
Regulations & Guidelines

MR-001 CNIL: what clinical trial sponsors must know about French health data compliance

Understand MR-001 CNIL obligations for clinical trial sponsors in France, from Article 32 security requirements to breach notification and cross-border data transfers.

A clinical trial coordinator reviewing an informed consent form alongside a data governance checklist, representing ICF boilerplate review and open-access database disclosure compliance
September 4, 2026
Guideline
EU Privacy Law
Regulations & Guidelines
Clinical Trials
United-Kingdom

ICF Boilerplate and Open-Access Database Disclosures: What Clinical Trial Sponsors Must Know

Learn how US site ICF boilerplate on commercial products and open-access genetic databases affects sponsor data governance, Common Rule compliance and GDPR obligations.

Abstract digital network graphic representing data protection, clinical trial compliance and cybersecurity themes for the iliomad weekly digest
September 3, 2026
Regulations & Guidelines
GDPR
Data Breach & Cybersecurity
LLMS

iliomad Weekly Digest: DPO Conflicts, Bulk Data Rules, Healthcare Cyber Incidents and AI Transparency

This week: CNIL on DPO conflicts of interest, DOJ bulk data rule for life sciences, wave of healthcare ransomware attacks, Uber's €825m GDPR fine and AI disclosure demands.